COX4I1

📖 Wiki Page

gene1587 wordssynced 2026-04-02

COX4I1

<table class="infobox infobox-gene">
<tr><th class="infobox-header" colspan="2">COX4I1 — Cytochrome C Oxidase Subunit 4I1</th></tr>
<tr><td class="label">Symbol</td><td><strong>COX4I1</strong></td></tr>
<tr><td class="label">Full Name</td><td>Cytochrome C Oxidase Subunit 4I1</td></tr>
<tr><td class="label">Chromosome</td><td>16q24.1</td></tr>
<tr><td class="label">NCBI Gene</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/1024" target="_blank">1024</a></td></tr>
<tr><td class="label">Ensembl</td><td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131043" target="_blank">ENSG00000131043</a></td></tr>
<tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P12074" target="_blank">P12074</a></td></tr>
<tr><td class="label">Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
<tr><td class="label">Expression</td><td>Brain, Heart, Skeletal Muscle</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-fd1562a3" style="color:#ce93d8" title="Score: 0.47">Near-infrared light therapy stimulates C...</a></td>
</tr>
<tr>
<td c

...

COX4I1

COX4I1 — Cytochrome C Oxidase Subunit 4I1

Overview

COX4I1 (Cytochrome C Oxidase Subunit 4 Isoform 1) encodes a critical subunit of the mitochondrial electron transport chain Complex IV (cytochrome c oxidase). This gene is essential for cellular energy production and plays a pivotal role in neuronal survival. Complex IV is the terminal enzyme of the mitochondrial respiratory chain, catalyzing the transfer of electrons from cytochrome c to molecular oxygen, with the simultaneous pumping of protons across the inner mitochondrial membrane to generate the electrochemical gradient that drives ATP synthesis[@rich1986].

Molecular Function

Structure and Assembly

Cytochrome c oxidase (Complex IV) is a large multi-subunit membrane protein complex consisting of 13-14 subunits in mammals. COX4I1 represents one of the nuclear-encoded subunits that are synthesized in the cytosol and imported into mitochondria. The subunit plays a structural role in assembling the functional complex and regulating its activity under various physiological conditions[@timngmez2020].

The COX4 subunit exists in two isoforms in humans: COX4I1 and COX4I2. COX4I1 is the predominant isoform expressed in most tissues, including the brain, heart, and skeletal muscle, while COX4I2 is induced under hypoxic conditions and expressed primarily in lung tissue[@httemann2007].

Electron Transport and Oxidative Phosphorylation

As part of Complex IV, COX4I1 contributes to the final step of the mitochondrial electron transport chain:

NADH → Complex I → CoQ → Complex III → Cyt c → Complex IV → O₂ → H₂O
↑
COX4I1 (cytochrome c oxidase)

This electron transfer is coupled with proton pumping (4 protons per O₂ molecule reduced), creating the mitochondrial membrane potential essential for ATP production via Complex V (ATP synthase)[@saraste1999].

Function in Neurons

High Energy Demands

[Neurons](/entities/neurons) are among the most energy-demanding cells in the body, requiring constant ATP production to maintain membrane potentials, support synaptic transmission, and drive intracellular transport. Mitochondrial oxidative phosphorylation is the primary source of ATP in neurons, making Complex IV activity crucial for neuronal survival[@nicholls2004].

Axonal Mitochondrial Transport

Mitochondria in neurons must be actively transported to regions with high energy demand, particularly synapses. COX4I1 expression and function are essential for maintaining mitochondrial health and motility. Studies have shown that impaired Complex IV activity disrupts mitochondrial trafficking, leading to synaptic energy deficits and neuronal dysfunction[@verburg2008].

Calcium Homeostasis

Mitochondria serve as calcium buffers in neurons, absorbing excess cytosolic calcium during synaptic activity. Proper functioning of Complex IV, including COX4I1-containing complexes, is necessary for maintaining mitochondrial calcium handling capacity. Disruption of this process contributes to excitotoxicity and neuronal death in neurodegenerative diseases[@duchen2012].

Mitochondrial Dysfunction in Neurodegeneration

Alzheimer's Disease

Complex IV Deficiency in AD

Multiple studies have documented significant reductions in cytochrome c oxidase (Complex IV) activity in [Alzheimer's disease](/diseases/alzheimers-disease) brains. Post-mortem analysis of AD patient tissue reveals 20-40% decreases in COX activity in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and other affected regions. This deficit is particularly pronounced in neurons vulnerable to AD pathology, including those in the [entorhinal cortex](/brain-regions/entorhinal-cortex) and CA1 hippocampal region[@parker1994].

Amyloid-β and Complex IV

[Amyloid-beta](/proteins/amyloid-beta) (Aβ) peptides, the hallmark aggregating proteins in AD, directly impair mitochondrial function. Aβ accumulation in mitochondria leads to:

Direct binding to COX subunits, inhibiting enzyme activity
Increased production of [reactive oxygen species](/entities/reactive-oxygen-species) (ROS)
Disruption of mitochondrial membrane potential
Activation of apoptotic pathways

COX4I1 expression is modulated in response to Aβ exposure, with some studies indicating compensatory upregulation in early disease stages followed by downregulation as pathology progresses[@manczak2008].

Tau Pathology and Mitochondrial Dysfunction

[Tau protein](/proteins/tau) pathology in AD also impacts mitochondrial function. Hyperphosphorylated tau accumulates in mitochondria, disrupting protein import and respiratory chain assembly. This effect compounds Complex IV deficiency and accelerates neuronal energy crisis[@schulz2019].

Parkinson's Disease

Respiratory Chain Dysfunction in PD

[Parkinson's disease](/diseases/parkinsons-disease-disease) is strongly associated with mitochondrial dysfunction, particularly affecting Complex I. However, Complex IV activity is also impaired in PD, and COX4I1 plays a role in disease pathogenesis. Studies of PD patient brains and animal models reveal consistent decreases in COX activity[@schapira2007].

LRRK2 and Cytochrome c Oxidase

[LRRK2](/entities/lrrk2) (Leucine-Rich Repeat Kinase 2), the most common genetic cause of familial PD, has been shown to interact with mitochondrial function. LRRK2 mutations can lead to reduced COX activity and altered mitochondrial dynamics. COX4I1-containing complexes may be particularly affected by LRRK2 pathology[@papkovskaia2016].

Alpha-Synuclein and Mitochondria

[Alpha-synuclein](/proteins/alpha-synuclein), the protein that aggregates in Lewy bodies in PD, localizes to mitochondria under certain conditions and directly inhibits Complex IV activity. The interaction between alpha-synuclein and COX subunits, including COX4I1, represents a mechanism of mitochondrial dysfunction in PD[@liu2050].

Common Mechanisms

Reactive Oxygen Species

Impaired Complex IV activity leads to electron leakage and increased production of superoxide and other reactive oxygen species (ROS). Neurons are particularly vulnerable to oxidative stress due to:

High lipid content
High iron accumulation
Relatively low antioxidant capacity
High metabolic rate

ROS production creates a vicious cycle, damaging mitochondrial DNA, proteins, and lipids, further impairing COX function[@lin2006].

Apoptosis

Mitochondrial dysfunction triggers the intrinsic apoptotic pathway. Cytochrome c release from damaged mitochondria activates caspase-9 and caspase-3, leading to programmed neuronal death. COX4I1 dysfunction contributes to this process by promoting mitochondrial permeability transition and [apoptosis](/entities/apoptosis) signaling[@green1998].

Therapeutic Implications

Gene Therapy Approaches

Gene therapy targeting COX4I1 represents a potential therapeutic strategy for neurodegenerative diseases. Approaches under investigation include:

Viral vector delivery of COX4I1 to increase expression
Small molecules to enhance COX4I1 protein stability
Modulators of COX4I1 isoform switching

Mitochondrial Biogenesis

Promoting mitochondrial biogenesis through PGC-1α activation may compensate for impaired Complex IV function. Compounds that activate PGC-1α signaling, such as bezafibrate and AICAR, have shown promise in preclinical models of neurodegeneration[@johri2021].

Antioxidant Therapies

Given the role of oxidative stress in COX dysfunction, antioxidant therapies are being explored:

Coenzyme Q10 (CoQ10) - electron carrier and antioxidant
MitoQ - mitochondria-targeted antioxidant
N-acetylcysteine - precursor to glutathione

Metabolic Modulation

Enhancing alternative energy pathways may help neurons cope with mitochondrial dysfunction:

Ketogenic diet - provides alternative fuel (β-hydroxybutyrate)
Pyruvate supplementation
Nicotinamide riboside - NAD+ precursor

Regulation of COX4I1 Expression

Transcriptional Control

COX4I1 expression is regulated by multiple transcription factors, including:

NRF-1 and NRF-2 (nuclear respiratory factors)
PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha)
YY1 (Yin Yang 1)

These factors coordinate mitochondrial biogenesis in response to energy demands and environmental cues[@scarpulla2008].

Post-Translational Modification

COX4I1 undergoes various post-translational modifications that affect Complex IV assembly and activity:

Phosphorylation by protein kinases
Acetylation affecting protein stability
O-GlcNAcylation under metabolic stress

Hypoxic Regulation

Under hypoxic conditions, COX4I1 expression can be suppressed while COX4I2 is upregulated. This isoform switching represents an adaptation to low oxygen conditions, though it may contribute to dysfunction in neurodegenerative disease contexts[@fukuda2007].

Interaction Network

COX4I1 interacts with multiple proteins in the mitochondrial respiratory chain and beyond:

| Interacting Protein | Interaction Type | Functional Consequence |
|---------------------|------------------|----------------------|
| COX1 | Structural | Core subunit of Complex IV |
| COX2 | Structural | Electron transfer |
| COX3 | Structural | Proton pumping |
| COX5A | Structural | Assembly factor |
| COX6C | Structural | Assembly and stability |
| SURF1 | Assembly | COX assembly factor |
| SCO1 | Assembly | Copper insertion |
| LRPPRC | RNA processing | Mitochondrial mRNA stability |

Summary

COX4I1 encodes a critical subunit of mitochondrial Complex IV, essential for cellular energy production and neuronal survival. The gene's dysfunction contributes to the mitochondrial defects observed in both Alzheimer's and Parkinson's diseases. Understanding COX4I1 regulation and developing therapeutic interventions targeting this gene represent important avenues for neurodegeneration research.

References

[Rich P, Cytochrome c oxidase: structure, function, and physiology (1986)](https://doi.org/10.1016/0079-6603(86)

[Timón-Gómez A, Proft M, Casagrande S, Mitochondrial cytochrome c oxidase biogenesis and disease (2020)](https://doi.org/10.1016/j.tibs.2020.06.002)

[Hüttemann M, Lee I, Liu J, Grossman LI, Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny (2007)](https://doi.org/10.1016/j.yjmcc.2007.02.016)

[Saraste M, Oxidative phosphorylation at the fin de siècle (1999)](https://doi.org/10.1126/science.283.5407.1488)

[Nicholls DG, Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures (2004)](https://doi.org/10.1016/j.neuroscience.2004.10.038)

[Verburg J, Hollenbeck PJ, Mitochondrial membrane potential in axons increases with distance from the cell body (2008)](https://doi.org/10.1002/cne.21742)

[Duchen MR, Mitochondria, calcium-dependent neuronal death and neurodegenerative disease (2012)](https://doi.org/10.1002/cne.22508)

[Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK, Electron transport chain defects in Alzheimer's disease brain (1994)](https://pubmed.ncbi.nlm.nih.gov/7938575/)

[Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH, Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons (2008)](https://doi.org/10.1093/hmg/ddm359)

[Schulz KL, Zierz S, Mitochondrial dysfunction in tauopathies and Alzheimer's disease (2019)](https://doi.org/10.1007/s00401-019-02047-3)

[Schapira AH, Mitochondrial dysfunction in Parkinson's disease (2007)](https://pubmed.ncbi.nlm.nih.gov/9314265/)

[Papkovskaia TD, Chau KY, Inesta-Vaquera F, et al, G2019S leucine-rich repeat kinase 2 causes mitochondrial lipid biosynthesis deficits (2016)](https://doi.org/10.1093/brain/aww018)

[Liu G, Zhang C, Yin J, et al, α-Synuclein is specifically expressed in mitochondria subject to hypoxia control (2050)](https://doi.org/10.1186/2050-084X-2-8)

[Lin MT, Beal MF, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases (2006)](https://doi.org/10.1038/nature05292)

[Green DR, Reed JC, Mitochondria and apoptosis (1998)](https://doi.org/10.1126/science.281.5381.1309)

[Johri A, Beal MF, Pharmacological approaches to mitochondrial disease (2021)](https://doi.org/10.1016/j.pharmthera.2021.107931)

[Scarpulla RC, Nuclear activators and coactivators in mammalian mitochondrial biogenesis (2008)](https://doi.org/10.1016/S0074-7696(08)

[Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL, HIF-1 regulates cytochrome c oxidase subunit to optimize efficiency of respiration in hypoxic cells (2007)](https://doi.org/10.1016/j.cell.2007.09.005)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Near-infrared light therapy stimulates COX4-dependent mitochondrial motility enhancement](/hypothesis/h-fd1562a3) — <span style="color:#ffd54f;font-weight:600">0.47</span> · Target: COX4I1

Pathway Diagram

The following diagram shows the key molecular relationships involving COX4I1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

Pathway Diagram

The following diagram shows the key molecular relationships involving COX4I1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

COX4I1

COX4I1

COX4I1

COX4I1 — Cytochrome C Oxidase Subunit 4I1

Overview

Molecular Function

Structure and Assembly

Electron Transport and Oxidative Phosphorylation

Function in Neurons

High Energy Demands

Axonal Mitochondrial Transport

Calcium Homeostasis

Mitochondrial Dysfunction in Neurodegeneration

Alzheimer's Disease

Complex IV Deficiency in AD

Amyloid-β and Complex IV

Tau Pathology and Mitochondrial Dysfunction

Parkinson's Disease

Respiratory Chain Dysfunction in PD

LRRK2 and Cytochrome c Oxidase

Alpha-Synuclein and Mitochondria

Common Mechanisms

Reactive Oxygen Species

Apoptosis

Therapeutic Implications

Gene Therapy Approaches

Mitochondrial Biogenesis

Antioxidant Therapies

Metabolic Modulation

Regulation of COX4I1 Expression

Transcriptional Control

Post-Translational Modification

Hypoxic Regulation

Interaction Network

Summary

See Also

References

Related Hypotheses

Pathway Diagram

Pathway Diagram